Disc Medicine, Inc. (IRON): Submission of Matters to a Vote of Security Holders
Disc Medicine, Inc. (IRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001816736 0001816736 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18,
How this was made
The 30-second read
Why it matters
Because the items are standard proxy matters (Class III director election, non-binding advisory executive compensation approval, and ratification of the independent auditor), the disclosure is primarily administrative and does not introduce new fundamentals.
Market read
This is a formal record of proxy voting outcomes; it is unlikely to drive trading beyond routine governance noise.
What to watch
Traders may still watch for subsequent 10-Q/10-K disclosures or any board/management changes that could stem from the meeting outcomes, though none are stated here.
Background
The company’s 8-K (Item 5.07) summarizes final results of three proposals voted on at its June 18, 2026 annual meeting, referencing a Schedule 14A proxy filed April 28, 2026.
Ticker impact
Disc Medicine filed an 8-K with final voting results from its June 18, 2026 annual meeting, including director elections and auditor ratification.
Limited near-term impact; any reaction likely muted unless votes signal governance/oversight concerns.
The filing reports standard proxy items (board election, advisory comp approval, and E&Y ratification) without new financial guidance, transactions, or enforcement actions.
Market effects
None—no sector-wide regulatory, clinical, or funding signal disclosed.
None—US Nasdaq-listed governance filing only.
None—no cross-border transaction or global regulatory action mentioned.
Counterpoint
If any proposal had unusually close vote counts, it could hint at shareholder dissatisfaction, but this filing provides no narrative or follow-on actions.
Key entities
- companyDisc Medicine, Inc.
Nasdaq-listed issuer that filed the 8-K reporting annual meeting vote results.
- auditorErnst & Young LLP
Independent registered public accounting firm ratified for the fiscal year ending December 31, 2026.
- director_nomineeDonald Nicholson, Ph.D.
Elected Class III director for a three-year term (as reported in the vote results).
- director_nomineeJohn Quisel, J.D., Ph.D.
Elected Class III director for a three-year term (as reported in the vote results).
- director_nomineeWilliam White, M.P.P., J.D.
Elected Class III director for a three-year term (as reported in the vote results).
